Integrated N- and O-Glycomics of Acute Myeloid Leukemia (AML) Cell Lines

Abstract excerpt

Acute myeloid leukemia (AML) is characterized by a dysregulated expansion of poorly differentiated myeloid cells. Although patients are usually treated effectively by chemotherapy, a high rate of relapsed or refractory disease poses a major hurdle in its treatment. Recently, several studies have proposed implications of protein glycosylation in the pathobiology of AML including chemoresistance. Accordingly,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acute Myeloid Leukemia Research
• Share to Glycosylation and Glycoproteins Research
• Share to Ubiquitin and proteasome pathways